Clin2
NCT07420036Possibly a fitNot yet recruiting

New PET tracer for imaging solid tumors

Neoplasms

Part of Cancer, Immune system & allergy clinical trials.

This study tests a new PET scan tracer that aims to highlight cancer cells more clearly. If you join, you'll receive one injection of the tracer and then have a PET/CT scan to help your doctor see whether you have cancer or where it is.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
98 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You likely have a solid tumor cancer (confirmed by biopsy or strongly suspected on scans), or your doctor thinks your cancer might have come back.
  • You need to be in fairly good health — able to do light activities and not needing to stay in bed most of the day.
  • You must be expected to live at least 6 more months.
  • If you could become pregnant (or have a partner who could), you must agree to use highly effective birth control from now until 6 months after the study injection.
  • You cannot be pregnant or breastfeeding, and you must not have had another radioactive tracer within the past few weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07708103Not yet recruiting· Early Phase 1
New PET imaging tracer for solid tumors

This study tests a new type of imaging agent (called a tracer) that helps PET scans see tumors more clearly. It may help doctors find and monitor cancer better.

Wuhan, Hubei
NCT07741006Enrolling by invitation· Early Phase 1
PET imaging study for adults with solid tumors

This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.

Wuhan, Hubei
NCT07385950Not yet recruiting
New imaging test for solid tumors

This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.

Wuhan, Hubei
NCT07045428Not yet recruiting· Phase 1
PET imaging drug for people with solid tumors

This trial tests an experimental PET imaging drug, called 68Ga-GP-01, to see if it can help show tumors and any spread of the cancer. The study will give you the imaging drug, then take a PET/CT scan. You may join if you have a solid tumor and are scheduled for surgery or a laparoscopic exploration to confirm the cancer.

NCT07639801Not yet recruiting
New PET scan for diagnosing solid tumors

This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.

NCT06720298Not yet recruiting
New imaging agent for PET scans in cancer

This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.

Beijing, Beijing Municipality

Hear when a new Neoplasms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.